Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 10,659 shares trading hands.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Calithera Biosciences in a research note on Friday. They issued a “hold” rating on the stock.
View Our Latest Research Report on CALA
Calithera Biosciences Price Performance
Calithera Biosciences Company Profile
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
Featured Stories
- Five stocks we like better than Calithera Biosciences
- Canada Bond Market Holiday: How to Invest and Trade
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Nebius Group: The Rising Star in AI Infrastructure
- What is a Low P/E Ratio and What Does it Tell Investors?
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
